News FluoRok secures £1.2M in funding strengthening the commercial proposition for the novel HF-free process for producing Fluorochemicals
News Accession Therapeutics awarded €7.5m Horizon Europe grant funding to advance TROCEPT-01 (ATTR-01), a first-in-class, tumour-activated immunotherapy
